DRW Holdings »

Theravance Biopharma shares owned by DRW Holdings

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by DRW Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $459k 28k 16.23

More positions owned by DRW Holdings

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
iShares Russell 2000 Index Call Option (IWM)
NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alphabet Inc Class A cs Call Option (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Tesla Motors Call Option (TSLA)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Astrazeneca Plc Each Ads Representing 1/2 Of An Or Ordinary Share Call Option (AZN)
Advanced Micro Devices Call Option (AMD)
Ishares Core Msci Emkt (IEMG)
Facebook Inc cl a Call Option (META)
Vestas Put Option (VWSYF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr China Lg-cap Etf (FXI)

View all positions for DRW Holdings

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Vanguard Capital Management
Acadian Asset Management
Two Sigma Investments
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
UBS Group

View all funds holding Theravance Biopharma